Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Association Studies of MICB and PLCE1 with Severity of Dengue in Indonesian and Taiwanese Populations. | Diagnostics (Basel) | 2023 | 37958261 | PubTator, text mining | PubMed |
| High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma. | BMC Cancer | 2023 | 37957631 | PubTator, text mining | PubMed |
| Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer. | Cancer Gene Ther | 2023 | 37949944 | PubTator, text mining | PubMed |
| Genome-Wide Assessment of Shared Genetic Architecture Between Rheumatoid Arthritis and Cardiovascular Diseases. | J Am Heart Assoc | 2023 | 37947095 | PubTator, text mining | PubMed |
| Identification of ASF1B as a prognostic marker for liver cancer by meta-analysis and its immune value revealed by a comprehensive pan-cancer analysis of 33 human cancers. | Prz Gastroenterol | 2023 | 37937108 | PubTator, text mining | PubMed |
| Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect. | J Transl Med | 2023 | 37932756 | PubTator, text mining | PubMed |
| Characterization of the genomic alterations in poorly differentiated thyroid cancer. | Sci Rep | 2023 | 37932340 | PubTator, text mining | PubMed |
| NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells. | Front Immunol | 2023 | 37928520 | PubTator, text mining | PubMed |
| Impact of a new liver immune status index among patients with hepatocellular carcinoma after initial hepatectomy. | Ann Gastroenterol Surg | 2023 | 37927921 | PubTator, text mining | PubMed |
| Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure. | Chin Med J (Engl) | 2023 | 37927030 | PubTator, text mining | PubMed |
| MICa/b-dependent activation of natural killer cells by CD64+ inflammatory type 2 dendritic cells contributes to autoimmunity. | EMBO J | 2023 | 37916875 | PubTator, text mining | PubMed |
| Dual targeting of H2S synthesizing enzymes; cystathionine β-synthase and cystathionine γ-lyase by miR-939-5p effectively curbs triple negative breast cancer. | Heliyon | 2023 | 37916110 | PubTator, text mining | PubMed |
| Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations. | Neoplasia | 2023 | 37913654 | PubTator, text mining | PubMed |
| Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis. | Front Immunol | 2023 | 37908350 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression. | Front Immunol | 2023 | 37901236 | PubTator, text mining | PubMed |
| Current Knowledge on the Interaction of Human Cytomegalovirus Infection, Encoded miRNAs, and Acute Aortic Syndrome. | Viruses | 2023 | 37896804 | PubTator, text mining | PubMed |
| RNA Editing-Dependent and -Independent Roles of Adenosine Deaminases Acting on RNA Proteins in Herpesvirus Infection-Hints on Another Layer of Complexity. | Viruses | 2023 | 37896783 | PubTator, text mining | PubMed |
| Extracellular Vesicles as a Translational Approach for the Treatment of COVID-19 Disease: An Updated Overview. | Viruses | 2023 | 37896755 | PubTator, text mining | PubMed |
| Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment. | Biomedicines | 2023 | 37892995 | PubTator, text mining | PubMed |
| CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification. | Cells | 2023 | 37887301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=13